These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7699677)

  • 41. On the determinants of the creatinine clearance: a population study.
    Kesteloot H; Joossens JV
    J Hum Hypertens; 1996 Apr; 10(4):245-9. PubMed ID: 8736456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
    Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
    Taha AS; Capell HA; Sturrock RD; Russell RI
    Am J Gastroenterol; 1991 Nov; 86(11):1588-91. PubMed ID: 1683150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin-induced depression of renal function.
    Kimberly RP; Plotz PH
    N Engl J Med; 1977 Feb; 296(8):418-24. PubMed ID: 834212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimalarial drugs for rheumatoid arthritis.
    Mackenzie AH
    Am J Med; 1983 Dec; 75(6A):48-58. PubMed ID: 6362406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimalarial treatment of rheumatoid arthritis.
    Zvaifler NJ
    Med Clin North Am; 1968 May; 52(3):759-64. PubMed ID: 5653948
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term use of antimalarial drugs in rheumatic diseases.
    Jover JA; Leon L; Pato E; Loza E; Rosales Z; Matias MA; Mendez-Fernandez R; Díaz-Valle D; Benitez-Del-Castillo JM; Abasolo L
    Clin Exp Rheumatol; 2012; 30(3):380-7. PubMed ID: 22339928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests.
    Soria A; Barbaud A; Assier H; Avenel-Audran M; Tétart F; Raison-Peyron N; Amarger S; Girardin P; Francès C;
    Dermatology; 2015; 231(4):353-9. PubMed ID: 26457932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prescribing of chloroquine and hydroxychloroquine by consultant rheumatologists in the UK.
    Kay EA; Rees JA; Jayson MI
    Br J Rheumatol; 1987 Oct; 26(5):375-8. PubMed ID: 3664163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.
    Arden GB; Kolb H
    Br Med J; 1966 Jan; 1(5482):270-3. PubMed ID: 5902055
    [No Abstract]   [Full Text] [Related]  

  • 53. The EOG in rheumatoid arthritis.
    Pinckers A; Broekhuyse RM
    Acta Ophthalmol (Copenh); 1983 Oct; 61(5):831-7. PubMed ID: 6659891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.
    SCHERBEL AL; SCHUCHTER SL; HARRISON JW
    Cleve Clin Q; 1957 Apr; 24(2):98-104. PubMed ID: 13427154
    [No Abstract]   [Full Text] [Related]  

  • 55. THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
    KERSLEY GD
    Proc R Soc Med; 1964 Aug; 57(8):669-71. PubMed ID: 14195851
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine.
    Riley K; Schwager Z; Stern M; Vleugels RA; Femia A
    JAMA Dermatol; 2019 Apr; 155(4):491-493. PubMed ID: 30758479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimalarial drugs alone may still have a role in rheumatoid arthritis.
    Cusnir I; Dobing S; Jones N; Russell A
    J Clin Rheumatol; 2015 Jun; 21(4):193-5. PubMed ID: 26010182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacokinetics of slow-acting antirheumatic drugs.
    Tett SE
    Clin Pharmacokinet; 1993 Nov; 25(5):392-407. PubMed ID: 7904547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.
    Casado E; Gratacós J; Tolosa C; Martínez JM; Ojanguren I; Ariza A; Real J; Sanjuán A; Larrosa M
    Ann Rheum Dis; 2006 Mar; 65(3):385-90. PubMed ID: 16096334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity to UV light during treatment with chloroquine in rheumatoid arthritis.
    Seideman P; Ros AM
    Scand J Rheumatol; 1992; 21(5):245-7. PubMed ID: 1439633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.